GlassScriptPhysician profile
Mhd Khaled Alshalian
NPI 1679806707
$796.79
in general payments reported to CMS, 2019-2025
20 companies · $33.97 in 2025
The $33.97 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $74.81 · 2021: $49.20 · 2022: $245 · 2023: $217 · 2024: $41.39 · 2025: $33.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $292.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $441.28 | 2022-2025 | Qulipta, Ubrelvy |
| Novartis Pharmaceuticals Corporation | $35.83 | 2019-2020 | |
| Biogen, INC. | $33.45 | 2020 | |
| Sk Life Science, INC. | $27.50 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.98 | 2022 | |
| Argenx US, INC. | $23.00 | 2022 | |
| Lundbeck LLC | $21.12 | 2022 | |
| Emd Serono, INC. | $18.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.86 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $16.90 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.42 | 2019 | |
| Horizon Therapeutics Plc | $14.63 | 2023 | Uplizna |
| Allergan, INC. | $14.44 | 2021 | |
| Acorda Therapeutics, INC | $13.67 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.57 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $13.57 | 2019 | |
| Lilly USA, LLC | $13.31 | 2019 | |
| Genentech USA, INC. | $13.00 | 2019 | |
| Impel Pharmaceuticals INC. | $12.16 | 2022 | |
| Amneal Pharmaceuticals LLC | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mhd Khaled Alshalian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.